Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-004249

CVP,Strategy/Corp Development sold 22,680 shares at an average $80.16 ($1,818,055)

  • CVP,Strategy/Corp Development acquired 22,680 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BOBO DONALD E JR · CVP,Strategy/Corp Development

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-02 Exercise or conversion : show line 1 in the form 10b5-1 +22,680 $59.26 $1,343,942 43,946.25 D
2026-04-02 Sale : show line 2 in the form 10b5-1 −4,676 $80.59 $376,846 39,270.25 D
2026-04-02 Sale : show line 3 in the form 10b5-1 −18,004 $80.05 $1,441,209 21,266.25 D
Open-market sales · 22,680 sh · avg $80.16 · $1,818,055

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-02 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) −22,680 0 D
Loading xslF345X06/doc4.xml…